<DOC>
	<DOCNO>NCT00561002</DOCNO>
	<brief_summary>To provide Centers Biologic Evaluation Research ( CBER ) serum collect healthy child receive 2007-2008 formulation inactivate , split-virion influenza vaccine Fluzone® study .</brief_summary>
	<brief_title>Phase IV Trial Collect Safety Data Sera Immunogenicity Testing Healthy Children Given Fluzone® Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Participant age ≥ 6 month ( 24 week ) &lt; 36 month ( 3rd birthday ) . Participant consider good health basis report medical history limited physical examination . Participant available duration study . Parent/legal acceptable representative willing able provide inform consent . Parent/legal acceptable representative willing able meet protocol requirement . Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg ( 5.5 lb ) . Reported allergy egg protein , chicken protein , constituent vaccine . An acute illness without fever ( For infants/toddlers : temperature ≥ 100.4°F rectal ; For child : temperature ≥ 99.5°F oral/axillary ) 72 hour precede enrollment trial ( Enrollment may defer ) . Clinically significant finding vital sign review system ( Investigator judgment ; defer exclude ) . Participation interventional clinical trial within 30 day prior enrollment plan participation study . Known suspect impairment immunologic function , receipt immunosuppressive therapy immunoglobulin since birth . Personal immediate family history congenital immune deficiency . Developmental delay , neurologic disorder , seizure disorder . Chronic medical , congenital , developmental disorder . Known human immunodeficiency virus ( HIV ) positive mother . Prior personal history GuillainBarré syndrome . Any condition , opinion Investigator , would pose health risk subject interfere evaluation vaccine . Received vaccination within precede 14 day ( enrollment may defer ) .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Influenza Vaccine</keyword>
	<keyword>Influenza Virus</keyword>
	<keyword>Orthomyxoviridae Infections</keyword>
	<keyword>Fluzone®</keyword>
</DOC>